AbCellera Biologics (ABCL) Cash & Current Investments (2020 - 2026)
AbCellera Biologics' Cash & Current Investments was $540.1 million in Q2 2026, down 2.3% from $553.08 million a year earlier but up 7.0% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at AbCellera Biologics came in at $533.83 million, down 14.7% from FY2024.
- Cash & Current Investments has now declined for three consecutive years, with a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $625.61 million in FY2024 (-17.7%), $760.59 million in FY2023 (-14.2%), $886.49 million in FY2022 (+22.6%) and $722.98 million in FY2021 (+21.7%).
- Quarterly Cash & Current Investments has moved between $495.67 million (Q3 2025) and $1.02 billion (Q2 2022) over five years.
- Compared with a year earlier, Cash & Current Investments has declined for 13 straight quarters, with an average decline of 15.4% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q3 2022 (growth of 67.7%); the worst was Q3 2025 (a decline of 22.9%).
- Per Business Quant data, ABCL's Cash & Current Investments in the three quarters before Q2 2026 was $504.73 million (Q1 2026), $533.83 million (Q4 2025) and $495.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | AbCellera Biologics | 3.62 Bn | 3.08 Bn | - | 540.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 540.10 Mn |
| Mar 31, 2026 | 504.73 Mn |
| Dec 31, 2025 | 533.83 Mn |
| Sep 30, 2025 | 495.67 Mn |
| Jun 30, 2025 | 553.08 Mn |
| Mar 31, 2025 | 605.27 Mn |
| Dec 31, 2024 | 625.61 Mn |
| Sep 30, 2024 | 643.14 Mn |
| Jun 30, 2024 | 670.36 Mn |
| Mar 31, 2024 | 698.02 Mn |
| Dec 31, 2023 | 760.59 Mn |
| Sep 30, 2023 | 785.84 Mn |
| Jun 30, 2023 | 795.69 Mn |
| Mar 31, 2023 | 796.50 Mn |
| Dec 31, 2022 | 886.49 Mn |
| Sep 30, 2022 | 868.21 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 786.05 Mn |
| Dec 31, 2021 | 722.98 Mn |
| Sep 30, 2021 | 517.69 Mn |
API Access
AbCellera Biologics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();